SNP | IGT/Diabetes present %(n) | P value | Hypertension present %(n) | P value | |
---|---|---|---|---|---|
APOA5 (-1131T >C) (Dominant Model) | TT & TC | 15.2 (1093) | 0.168 | 9.6 (1132) | 0.387 |
CC | 22.0 (41) | 11.9 (42) | |||
APOA5 (-1131T >C) (Recessive Model) | TT | 14.9 (753) | 0.258 | 10.4 (778) | 0.151 |
TC &CC | 16.5(381) | 8.3 (396) | |||
APOA5 (S19W) (Dominant Model) | SS & SW | 15.3 (1044) | 0.717 | 8.9 (1087) | 0.246 |
WW | 0.0 (2) | 33.3 (3) | |||
APOA5 (S19W) (Recessive Model) | SS | 15.6 (967) | 0.203 | 8.8 (1008) | 0.312 |
SW&WW | 11.4 (79) | 11.0 (82) | |||
HL (C-514T) (Dominant Model) | CC & CT | 15.6 (1151) | 0.233 | 9.8 (1192) | 0.480 |
TT | 19.4 (72) | 10.5 (76) | |||
HL (C-514T) (Recessive Model) | CC | 14.3 (732) | 0.055 | 9.5 (761) | 0.313 |
CT&TT | 17.9 (491) | 10.5 (507) | |||
PPARγ (Pro12Ala) (Dominant Model) | Pro12Pro & Pro12Ala | 15.5 (1104) | 0.546 | 9.6 (1148) | 0.476 |
Ala12Ala | 16.7 (18) | 5.6 (18) | |||
PPARγ (Pro12Ala) (Recessive Model) | Pro12Pro | 15.2 (884) | 0.297 | 8.7 (921) | 0.042 |
Pro12Ala & Ala12Ala | 16.8 (238) | 12.7 (245) |